Abstract:Background: Cluster of differentiation 36 (CD36) is a transmembrane glycoprotein involved in many biological processes, such as platelet biology, angiogenesis and in the aetiopathology of atherosclerosis and cardiovascular diseases. Toll-like receptors (TLRs) are one of the most important receptors of the innate immune system. Their main function is the recognition of conserved structure of microorganisms. This recognition triggers signaling pathways that activate transcription of cytokines and co-stimulatory molecules which participate in the generation of an immune response against microbes. In particular, TLR2 has been shown to recognize a broad range of ligands. Recently, we showed that CD36 serves as a co-receptor for TLR2 and enhances recognition of specific diacylglycerides derived from bacteria.Methodology/Principal Findings: Here, we investigate the mechanism by which CD36 contributes to ligand recognition and activation of TLR2 signaling pathway. We show that the ectodomain of murine CD36 (mCD36ED) directly interacts with negatively charged diacylglycerol ligands, which explains the specificity and selectivity of CD36 as a TLR2 co-receptor. We also show that mCD36ED amplifies the pro-inflammatory response to lipoteichoic acid in macrophages of wild-type mice and restores the pro-inflammatory response of macrophages from mice deficient in CD36 (oblivious), but not from mice deficient in cluster of differentiation 14 (CD14) (heedless).Conclusion/Significance: These data indicate that the CD36 ectodomain is the only relevant domain for activation of TLR2 signaling pathway and that CD36 and CD14 have a non-redundant role for loading ligands onto TLR2 in the plasma-membrane. The pro-inflammatory role of soluble CD36 can be relevant in the activation of the immune response against pathogens, as well as in the progression of chronic diseases. Therefore, an increased level of soluble forms of CD36, which has been reported to be increased in type II diabetic patients, could accelerate atherosclerosis by increasing the pro-inflammatory response to diacylglycerol ligands.

CD154 is released from T-cells by a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) and ADAM17 in a CD40 protein-dependent manner

CD154 Resistant to Cleavage from Intracellular Milieu and Cell Surface Induces More Potent CD40-Mediated Responses

Soluble CD40 Ligand Stimulates CD40-Dependent Activation of the Β2 Integrin Mac-1 and Protein Kinase C Zeda (pkcζ) in Neutrophils: Implications for Neutrophil-Platelet Interactions and Neutrophil Oxidative Burst

Slowly getting a clue on CD95 ligand biology.

A Molecular Switch To Control Tnfr2 During Atherogenesis In Vivo

Differential regulation of soluble and membrane CD40L proteins in T cells

Novel Functions of Integrins as Receptors of CD154: Their Role in Inflammation and Apoptosis

Tetraspanins Regulate ADAM10-Mediated Cleavage of TNF-alpha and Epidermal Growth Factor

CD40/CD154 Ligation Induces Mononuclear Cell Adhesion to Human Renal Proximal Tubule Cells Via Increased ICAM-1 Expression.

Identification of an ADAM17 Cleavage Region in Human CD16 (FcγRIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells

TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association.

Role of ADAM10 and ADAM17 in CD16b Shedding Mediated by Different Stimulators.

Evaluation of the Contribution of Different ADAMs to Tumor Necrosis Factor Α (tnfα) Shedding and of the Function of the TNFα Ectodomain in Ensuring Selective Stimulated Shedding by the TNFα Convertase (TACE/ADAM17)

Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8 + T cell effector differentiation and anti-tumor immunity

Ectodomain shedding of Fcalpha receptor is mediated by ADAM10 and ADAM17.

Soluble Cd36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands And Acts As A Co-Receptor For Tlr2

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

Advances in the Study on CD154 Transcriptional Regulation

CD40: a Pivotal Receptor in the Determination of Life/death Decisions in B Lymphocytes.

Implications of CD154 and Its Receptors in the Pathogenesis and Treatment of Systemic Lupus Erythematosus

Proteolytic Release Of The P75(Ntr) Intracellular Domain By Adam10 Promotes Metastasis And Resistance To Anoikis